Celestica Inc: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on Apr 27, 2026 and accepted by EDGAR at Apr 27, 2026, 16:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2026-01-01 to 2026-03-31 | $4.05bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2026-01-01 to 2026-03-31 | $3.61bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2026-01-01 to 2026-03-31 | $437.2m | us-gaap:GrossProfit |
| Research and development | 3 months2026-01-01 to 2026-03-31 | $41.2m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2026-01-01 to 2026-03-31 | $117.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2026-01-01 to 2026-03-31 | $272.1m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2026-01-01 to 2026-03-31 | $16.0m | us-gaap:InterestExpenseNonoperating |
| Income tax | 3 months2026-01-01 to 2026-03-31 | $44.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $212.3m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $1.83 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $1.85 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 115,700,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-01-01 to 2026-03-31 | $356.3m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2026-01-01 to 2026-03-31 | $229.5m | us-gaap:PaymentsToAcquireProductiveAssets |
| Share repurchases | 3 months2026-01-01 to 2026-03-31 | $22.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2026-03-31 | $378.0m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2026-03-31 | $6.40bn | us-gaap:AssetsCurrent |
| Total assets | At period end2026-03-31 | $8.26bn | us-gaap:Assets |
| Current liabilities | At period end2026-03-31 | $5.08bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2026-03-31 | $6.16bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | $2.10bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001030894-26-000032. Last ingested by Listed: Oct 27, 2026, 07:19 ET. Listed shows no prices and gives no investment advice.